anonymous
Guest
anonymous
Guest
Paul Singer billionaire CEO of Elliott pressured GSK’s board to oust the CEO because she was more focused on consumer products than on pharma. He also installed Twitter’s new pharma shill CEO. And of course Singer was initially behind the Steele Dossier.
GlaxoSmithKline shares jump at news of activist hedge fund interest
UK drugmaker GSK under fresh pressure to sell consumer arm
GlaxoSmithKline shares jump at news of activist hedge fund interest
UK drugmaker GSK under fresh pressure to sell consumer arm